These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28756593)

  • 41. Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Chassot A; Canale S; Varlet P; Puget S; Roujeau T; Negretti L; Dhermain F; Rialland X; Raquin MA; Grill J; Dufour C
    J Neurooncol; 2012 Jan; 106(2):399-407. PubMed ID: 21858607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
    Gupta T; Mohanty S; Moiyadi A; Jalali R
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1814-9. PubMed ID: 23764039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
    Minniti G; Lanzetta G; Scaringi C; Caporello P; Salvati M; Arcella A; De Sanctis V; Giangaspero F; Enrici RM
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):93-9. PubMed ID: 22079725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma.
    Wang TJC; Wu CC; Jani A; Estrada J; Ung T; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Saadatmand HJ; Saraf A; Garrett MD; Grubb C; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; McKhann GM
    Pract Radiat Oncol; 2016; 6(5):306-314. PubMed ID: 26952813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.
    Chaskis C; Neyns B; Michotte A; De Ridder M; Everaert H
    Surg Neurol; 2009 Oct; 72(4):423-8. PubMed ID: 19150114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.
    Lin AJ; Campian JL; Hui C; Rudra S; Rao YJ; Thotala D; Hallahan D; Huang J
    J Neurooncol; 2018 Jan; 136(2):403-411. PubMed ID: 29143923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.
    Blakeley JO; Grossman SA; Mikkelsen T; Rosenfeld MR; Peereboom D; Nabors LB; Chi AS; Emmons G; Garcia Ribas I; Supko JG; Desideri S; Ye X
    J Neurooncol; 2015 Oct; 125(1):123-31. PubMed ID: 26285766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.
    Vinjamuri M; Adumala RR; Altaha R; Hobbs GR; Crowell EB
    J Neurooncol; 2009 Jan; 91(2):221-5. PubMed ID: 18813874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
    Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
    Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma.
    Zhou Z; Howard TA; Villano JL
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):1043-1046. PubMed ID: 28791452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
    Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined temozolomide and radiation as an initial treatment for anaplastic glioma.
    Tham CK; See SJ; Tan SH; Lim KH; Ng WH; Thomas J; Chong DQ; Chua ET
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):220-5. PubMed ID: 23279669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
    Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH
    Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.
    Gerber DE; Grossman SA; Zeltzman M; Parisi MA; Kleinberg L
    Neuro Oncol; 2007 Jan; 9(1):47-52. PubMed ID: 17108062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profile Analysis of Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.
    Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Akutsu H; Onuma K; Matsumura A
    Neurol Med Chir (Tokyo); 2015; 55(9):749-55. PubMed ID: 26345664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiotherapy and temozolomide for anaplastic astrocytic gliomas.
    Nayak L; Panageas KS; Reiner AS; Huse JT; Pentsova E; Braunthal SG; Abrey LE; DeAngelis LM; Lassman AB
    J Neurooncol; 2015 May; 123(1):129-34. PubMed ID: 25920709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
    Zhu P; Du XL; Lu G; Zhu JJ
    Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
    Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
    J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.
    Huang J; DeWees TA; Badiyan SN; Speirs CK; Mullen DF; Fergus S; Tran DD; Linette G; Campian JL; Chicoine MR; Kim AH; Dunn G; Simpson JR; Robinson CG
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1000-1007. PubMed ID: 26025775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The safety of temozolomide in the treatment of malignancies.
    Trinh VA; Patel SP; Hwu WJ
    Expert Opin Drug Saf; 2009 Jul; 8(4):493-9. PubMed ID: 19435405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.